Skip to main content
Log in

In Taiwan, the prescribing of antihyperlipidaemics shifted from fibric acid derivatives to statins over a 7-year period,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Chiang C-W, Chiu H-F, Chen C-Y, Wu H-L, Yang C-Y.Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003(a,a). Pharmacoepidemiology and Drug Safety 17: 62-69, No. 1, Jan 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

In Taiwan, the prescribing of antihyperlipidaemics shifted from fibric acid derivatives to statins over a 7-year period,. Pharmacoecon. Outcomes News 548, 9 (2008). https://doi.org/10.2165/00151234-200805480-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805480-00026

Keywords

Navigation